Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gordon J Freeman

Showing results (341-350 of 348) with videos related to

Pageof 35
Sort By:
You have reached the last page of results.This site can display upto 348 results.
Nature|April 9, 2025
Immune checkpoint TIM-3 regulates microglia and Alzheimer's diseaseKimitoshi Kimura, Ayshwarya Subramanian, Zhuoran Yin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2021
Association of <i>Fusobacterium nucleatum</i> with Specific T-cell Subsets in the Colorectal Carcinoma MicroenvironmentJennifer Borowsky, Koichiro Haruki, Mai Chan Lau, et al.
Science Translational Medicine|February 18, 2021
Epitope spreading toward wild-type melanocyte-lineage antigens rescues suboptimal immune checkpoint blockade responsesJennifer A Lo, Masayoshi Kawakubo, Vikram R Juneja, et al.
The Journal of Clinical Investigation|June 14, 2016
Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethalityAsim Saha, Roddy S O'Connor, Govindarajan Thangavelu, et al.
Cell|February 16, 2021
Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysisNathan D Mathewson, Orr Ashenberg, Itay Tirosh, et al.
Cancer Cell|December 30, 2019
CDK7 Inhibition Potentiates Genome Instability Triggering Anti-tumor Immunity in Small Cell Lung CancerHua Zhang, Camilla L Christensen, Ruben Dries, et al.
Cancer Discovery|November 5, 2017
CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell ActivationJiehui Deng, Eric S Wang, Russell W Jenkins, et al.
Cancer Discovery|November 5, 2017
<i>Ex Vivo</i> Profiling of PD-1 Blockade Using Organotypic Tumor SpheroidsRussell W Jenkins, Amir R Aref, Patrick H Lizotte, et al.
Pageof 35

Showing results (341-350 of 348) with videos related to

Sort By:
Pageof 35
You have reached the last page of results.This site can display upto 348 results.
Nature|April 9, 2025
Immune checkpoint TIM-3 regulates microglia and Alzheimer's diseaseKimitoshi Kimura, Ayshwarya Subramanian, Zhuoran Yin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2021
Association of <i>Fusobacterium nucleatum</i> with Specific T-cell Subsets in the Colorectal Carcinoma MicroenvironmentJennifer Borowsky, Koichiro Haruki, Mai Chan Lau, et al.
Science Translational Medicine|February 18, 2021
Epitope spreading toward wild-type melanocyte-lineage antigens rescues suboptimal immune checkpoint blockade responsesJennifer A Lo, Masayoshi Kawakubo, Vikram R Juneja, et al.
The Journal of Clinical Investigation|June 14, 2016
Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethalityAsim Saha, Roddy S O'Connor, Govindarajan Thangavelu, et al.
Cell|February 16, 2021
Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysisNathan D Mathewson, Orr Ashenberg, Itay Tirosh, et al.
Cancer Cell|December 30, 2019
CDK7 Inhibition Potentiates Genome Instability Triggering Anti-tumor Immunity in Small Cell Lung CancerHua Zhang, Camilla L Christensen, Ruben Dries, et al.
Cancer Discovery|November 5, 2017
CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell ActivationJiehui Deng, Eric S Wang, Russell W Jenkins, et al.
Cancer Discovery|November 5, 2017
<i>Ex Vivo</i> Profiling of PD-1 Blockade Using Organotypic Tumor SpheroidsRussell W Jenkins, Amir R Aref, Patrick H Lizotte, et al.
Pageof 35